State-of-the-art in transposable element modulation affected by drugs in malignant prostatic cancer cells

Anna Terrazzan1,2, Riccardo Vanini1, Pietro Ancona1

  • 1Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

PubMed

Insights

Transposable elements (TEs) are implicated in prostate cancer progression. Research suggests certain antiviral drugs and chemotherapy may reduce TEs, offering new therapeutic avenues.

Area of Science:

  • Genomics
  • Cancer Biology
  • Pharmacology

Background:

  • Transposable elements (TEs) are increasingly recognized for their role in cancer development.
  • Their specific functions and interactions with genes in prostate cancer remain an active area of research.

Purpose of the Study:

  • To review the association between transposable elements (TEs) and genes in prostate cancer.
  • To examine the impact of various drug treatments on TE activity and expression in prostate cancer.
  • To explore the potential of targeting TEs in prostate cancer therapy.

Main Methods:

  • Literature review of articles from the PubMed database.
  • Construction of gene-TE and drug-TE interaction networks.
  • Analysis of TE expression patterns in response to different chemical drugs.

Main Results:

  • Specific TE types were linked to the expression of transcripts involved in carcinogenesis.
  • Different drug treatments exhibited unique patterns of TE reactivation.
  • Evidence suggests a correlation between antiviral drugs, chemotherapy, and reduced TE expression in prostate cancer patients.

Conclusions:

  • Transposable elements play a significant role in prostate cancer progression and gene expression.
  • Drug treatments can modulate TE activity, with potential implications for cancer therapy.
  • Antiviral drugs and chemotherapy may represent a strategy to reduce TEs in prostate cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K